您可以输入30

债券

您所在的位置:
济川药业2015年度财务决算报告
 
  第 111101 号)。公司 2015 年营业收入 376,783.64 万元,
    同比增额 78,142.42 万元,同比上升 26.17%;实现归属于上市公司股东的净利润
    68,657.12 万元,同比增额 16,717.86 万元,同比上升 32.19%,实现归属于上市
    公司股东扣除非经常性损益净利润 64,050.21 万元,同比增额 16,229.62 万元,
    同比上升 33.94%。
                                                           本期比上年
              项目                2015 年     2014 年                     2013 年
                                                           同期增减(%)
    营业收入(万元)               376,783.64   298,641.22         26.17    244,757.76
    归属于上市公司股东的净利
                                  68,657.12    51,939.26         32.19     40,272.40
    润(万元)
    归属于上市公司股东扣除非
    经常性损益净利润(万           64,050.21    47,820.59         33.94     36,018.74
    元)
    经营活动产生的现金流量净
                                  64,547.52    61,611.20          4.77     28,716.49
    额(万元)
    基本每股收益(元/股)              0.88        0.67          31.34         0.66
    稀释每股收益(元/股)              0.88        0.67          31.34         0.66
                                                           增加 2.37 个
    加权平均净资产收益率(%)         28.57       26.20                       42.35
                                                                百分点
    归属于上市公司股东的净资
                                 266,798.39   229,399.45         16.30    115,241.27
    产(万元)
    总资产(万元)                 358,542.21   335,771.60          6.78    201,445.42
    二、主营业务收入及毛利率情况
                                                                                       单位;万元
                                                             营业收入     营业成本
                                                  毛利率                                   毛利率比上
         分行业     营业收入       营业成本                  比上年增     比上年增
                                                  (%)                                    年增减(%)
                                                             减(%)      减(%)
    (1)工业       359,117.07     43,339.33        87.93       25.59        21.90                 0.36
    (2)商业        16,790.03     15,488.32         7.75       37.86        37.61                 0.17
    合       计     375,907.10     58,827.65        84.35       26.09        25.68                 0.05
    三、 公司主要财务数据分析
          1、     报告期内资产负债项目变化情况及重大变化的原因
                                                                                       单位:万元
                                   本期期                               本期期末
                                                            上期期末
                                   末数占                               金额较上
                                                            数占总资
    项目名称       本期期末数      总资产     上期期末数                期期末变             情况说明
                                                            产的比例
                                   的比例                                动比例
                                                             (%)
                                    (%)                                (%)
                                                                                      主要系现金分红及归还
    货币资金           27,046.13     7.54      64,505.62      19.21      -58.07
                                                                                      银行借款所致
                                                                                      主要系票据回笼增加所
    应收票据            2,433.18     0.68       1,566.61       0.47       55.31
                                                                                      致
                                                                                      主要系定期存款未到期
    应收利息               15.61     0.00          53.20       0.02      -70.65
                                                                                      利息影响所致
                                                                                      主要系报告期内子公司
                                                                                      东科制药征用土地向杨
    其他应收
                        1,214.29     0.34         222.45       0.07      445.88       凌农业高新技术产业示
      款
                                                                                      范区管委会交纳保证金
                                                                                      1,000.00 万元所致
                                                                                      主要系报告期内新增子
      存货             17,064.94     4.76      12,367.25       3.68       37.98       公司东科制药及销售规
                                                                                      模增加所致
    其他流动                                                                          主要系报告期内募集资
                       13,033.11     3.64      28,015.33       8.34      -53.48
      资产                                                                            金理财余额减少所致
                                                                                      主要系报告期内建设项
    在建工程           46,726.41    13.03      15,904.81       4.74      193.79
                                                                                      目投资增加所致
                                                                                      主要系报告期内新增子
    无形资产           20,977.99     5.85      14,134.16       4.21       48.42
                                                                                      公司东科制药所致
                                                                                      主要系收购非同一控制
      商誉             16,730.38     4.67           0.00       0.00               -
                                                                                      下东科制药所致
                                                                              主要系绿化费用摊销导
    长期待摊
                            58.55      0.02      416.21       0.12   -85.93   致长期待摊费用余额减
      费用
                                                                              少所致
                                                                              主要系期初包含收购东
    其他非流                                                                  科制药股权款 8400 万元
                          8,282.06     2.31    13,197.64      3.93   -37.25
      动资产                                                                  及本期预付工程设备款
                                                                              增加所致
                                                                              主要系报告期内已全部
    短期借款                 0.00      0.00    28,000.00      8.34     -100
                                                                              偿还银行借款所致
                                                                              主要系办理供应商承兑
    应付票据              7,131.35     1.99     4,339.69      1.29    64.33
                                                                              汇票增加所致
                                                                              主要系报告期内新增子
    预收款项               333.26      0.09      182.02       0.05    83.09
                                                                              公司东科制药所致
                                                                              主要系销售规模增加所
    应交税费              6,922.38     1.93     5,071.93      1.51    36.48
                                                                              致
                                                                              主要系固定资产加速折
    递延所得
                           915.67      0.26      132.32       0.04   592.03   旧额增加及非同一控制
      税负债
                                                                              下合并东科制药所致
    其他非流                                                                  主要系与资产相关的项
                             0.00      0.00       90.00       0.03     -100
      动负债                                                                  目到期所致
      2、主要费用及税费情况及变动分析
                                                                               单位:万元
     序                                                                       2015 年费用占营
               费用项目         2015 年          2014 年        变动比例%
     号                                                                       业收入比例(%)
      1     管理费用             31,788.75        26,016.05           22.19                  8.44
      2     销售费用           204,489.86        164,597.95           24.24                54.27
      3     财务费用                 -456.55        -310.55          -47.01                -0.12
      4     所得税费用           11,644.96         8,525.32           36.59                  3.09
          (1)财务费用下降的主要原因为本期银行贷款利息支出减少所致。
          (2)所得税费用增加的主要原因为报告期内利润增加,应纳税所得额增加所致。
    
  注:本信息仅代表专家个人观点仅供参考,据此投资风险自负。

(摘自世华财讯
【关闭窗口】